The present invention relates to sublingual films of Terbutaline comprising Terbutaline or pharmaceutically acceptable salts thereof and pharmaceutically acceptable excipients with a diffusion flux of 9-105µg/cm2/min through biological mucosal membranes equivalent to human oral mucosa.